BMC pharmacology & toxicology (BMC Pharmacol Toxicol)

Journal PubWeight™ 231.94‹?›

Top papers

Rank Title Year PubWeight™‹?›
51 CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients. 2014 0.83
52 Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages. 2012 0.83
53 Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study. 2013 0.83
54 Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. 2015 0.83
55 Overuse of antibiotics for the common cold - attitudes and behaviors among doctors in rural areas of Shandong Province, China. 2015 0.82
56 Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study. 2016 0.82
57 Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family. 2013 0.82
58 First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus. 2013 0.82
59 A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure. 2015 0.82
60 Comparing antibiotic self-medication in two socio-economic groups in Guatemala City: a descriptive cross-sectional study. 2015 0.82
61 The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis. 2013 0.82
62 Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study. 2016 0.82
63 Availability of medicines in public sector health facilities of two North Indian States. 2015 0.82
64 Prevalence, trends, patterns and associations of analgesic use in Germany. 2015 0.81
65 Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2. 2013 0.81
66 Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes. 2013 0.81
67 Hypersensitivity to oxaliplatin: clinical features and risk factors. 2014 0.81
68 Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. 2013 0.81
69 Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011. 2014 0.81
70 A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9-tetrahydrocannabinol (THC) by vaporisation. 2014 0.81
71 Is the standard dose of amoxicillin-clavulanic acid sufficient? 2014 0.81
72 Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus. 2013 0.81
73 Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain. 2014 0.81
74 An outpatient antibacterial stewardship intervention during the journey to JCI accreditation. 2014 0.81
75 Evaluation of drug-induced tissue injury by measuring alanine aminotransferase (ALT) activity in silkworm hemolymph. 2012 0.81
76 Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials. 2016 0.81
77 Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells. 2013 0.80
78 Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology. 2012 0.80
79 An interview with Philip Biggin, Section Editor for Computational, in silico and modelling studies. 2012 0.80
80 A meta-analysis of the proportion of antimicrobial resistant human Salmonella isolates in Ethiopia. 2014 0.80
81 Gloriosa superba poisoning mimicking an acute infection- a case report. 2015 0.80
82 Effects of packaging and storage conditions on the quality of amoxicillin-clavulanic acid - an analysis of Cambodian samples. 2013 0.80
83 Unplanned medication discontinuation as a potential pharmacovigilance signal: a nested young person cohort study. 2014 0.80
84 Indoxyl sulfate promotes apoptosis in cultured osteoblast cells. 2013 0.80
85 Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial. 2014 0.79
86 Influence of Vitamin C and Vitamin E on testicular zinc content and testicular toxicity in lead exposed albino rats. 2012 0.79
87 Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats. 2016 0.79
88 The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells. 2013 0.79
89 A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010. 2014 0.79
90 Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011. 2013 0.79
91 Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use. 2016 0.79
92 Palonosetron versus ondansetron as rescue medication for postoperative nausea and vomiting: a randomized, multicenter, open-label study. 2014 0.79
93 Characterisation of an aerosol exposure system to evaluate the genotoxicity of whole mainstream cigarette smoke using the in vitro γH2AX assay by high content screening. 2014 0.79
94 3-D DNA methylation phenotypes correlate with cytotoxicity levels in prostate and liver cancer cell models. 2013 0.79
95 Microbiological contamination in counterfeit and unapproved drugs. 2014 0.79
96 Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer. 2014 0.79
97 Predictive factors of self-medicated analgesic use in Spanish adults: a cross-sectional national study. 2014 0.79
98 Analgesic use in a Norwegian general population: change over time and high-risk use--The Tromsø Study. 2015 0.78
99 Anti-TNF inhibits the airways neutrophilic inflammation induced by inhaled endotoxin in human. 2014 0.78
100 Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report. 2016 0.78
Next 50